Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis1

By S. Luther, Afshin Bidgol, D. Hargreaves, A. Schmidt, Ying Xu, Jyothi Paniyadi, M. Matloubian, J. Cyster. Journal of Immunology, 2002

619 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Tertiary lymphoid structures in cancer (2022, background): “Differences in the detected TLS components have also been reported in distinct human cancer types (21, 27, 70), as, for instance, DCLAMP+ DCs have been described in TLSs in NSCLC but less in other cancer types (22, 24).”
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. (2008, background): “Follicular B cells and CD4 T cells in the spleen constitutively express LTαβ, but expression of LTαβ can be induced on splenic T cells by the cytokines IL-4 and IL-7 and the chemokine (C-C motif) ligands (CCL) 19 and 21 (Luther et al., 2002), and on a human T-cell line by TNF (Voon et al., 2004).”